GENETIC TESTING FOR ALL BREAST CANCER PATIENTS (GET FACTS)

NOT ENROLLING
Protocol # :
19-509
Conditions
Breast Cancer
Invasive Breast Cancer
in Situ Breast Cancer
Genetic Testing
Phase
Feasibility / Pilot
Disease Sites
Breast
Principal Investigator
King, Tari

Trial Description

This study is designed to determine the impact of a novel genetic counseling method on
surgical decisions in individuals with newly diagnosed breast cancer

This research study involves an expedited and surgery-specific form of genetic counseling.

The names of the study methods involved in this trial are/is:

- Quantitative genetic counseling (discussion is guided by tables and graphs)

- Standard genetic counseling

Eligibility Requirements

Inclusion Criteria

- Patients with a new breast cancer diagnosis (invasive or in-situ) considering genetic
testing

- Patients with good understanding of written and spoken English

- Patients with apparent cognitive capacity to make surgical decisions for themselves

- Patients who are medically cleared for surgery

- Patients must be at least age 18 but under 79

Exclusion Criteria

- Previous breast cancer diagnosis (invasive or DCIS)

- Metastatic breast cancer

- Patients who have received prior broad-based panel testing (prior BRCA1/2 testing with
negative results allowed)

- Bilateral breast cancer

- Known medical or surgical contraindication to contralateral mastectomy

- Hematologic malignancy necessitating skin biopsy/fibroblast culture for germline
genetic testing malignancy other than cervical cis or basal or squamous cell skin
cancers.

19-509